These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 11966443

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.
    Gharehbaghi K, Sreenath A, Hao Z, Paull KD, Szekeres T, Cooney DA, Krohn K, Jayaram HN.
    Biochem Pharmacol; 1994 Oct 07; 48(7):1413-9. PubMed ID: 7945441
    [Abstract] [Full Text] [Related]

  • 3. Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase.
    Gharehbaghi K, Grünberger W, Jayaram HN.
    Curr Med Chem; 2002 Apr 07; 9(7):743-8. PubMed ID: 11966437
    [Abstract] [Full Text] [Related]

  • 4. Modulation of cytotoxicity of benzamide riboside by expression of NMN adenylyltransferase.
    Yalowitz JA, Jayaram HN.
    Curr Med Chem; 2002 Apr 07; 9(7):749-58. PubMed ID: 11966438
    [Abstract] [Full Text] [Related]

  • 5. Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside.
    Damaraju VL, Visser F, Zhang J, Mowles D, Ng AM, Young JD, Jayaram HN, Cass CE.
    Mol Pharmacol; 2005 Jan 07; 67(1):273-9. PubMed ID: 15486050
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN, Cooney DA, Grusch M, Krupitza G.
    Curr Med Chem; 1999 Jul 07; 6(7):561-74. PubMed ID: 10390601
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of benzamide riboside in vitro and in vivo.
    Novotny L, Rauko P, Yalowitz JA, Szekeres T.
    Curr Med Chem; 2002 Apr 07; 9(7):773-9. PubMed ID: 11966441
    [Abstract] [Full Text] [Related]

  • 9. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P, Grifantini M.
    Curr Med Chem; 1999 Jul 07; 6(7):599-614. PubMed ID: 10390603
    [Abstract] [Full Text] [Related]

  • 10. Metabolism of the novel IMP dehydrogenase inhibitor benzamide riboside.
    Jäger W, Salamon A, Szekeres T.
    Curr Med Chem; 2002 Apr 07; 9(7):781-6. PubMed ID: 11966442
    [Abstract] [Full Text] [Related]

  • 11. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside.
    Pankiewicz KW, Watanabe KA, Lesiak-Watanabe K, Goldstein BM, Jayaram HN.
    Curr Med Chem; 2002 Apr 07; 9(7):733-41. PubMed ID: 11966436
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytotoxicity of tiazofurin and its arabinose and xylose analogues in K562 cells.
    Zhen W, Jayaram HN, Marquez VE, Goldstein BM, Cooney DA, Weber G.
    Biochem Biophys Res Commun; 1991 Oct 31; 180(2):933-8. PubMed ID: 1683233
    [Abstract] [Full Text] [Related]

  • 16. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
    Wright DG, Boosalis M, Malek K, Waraska K.
    Leuk Res; 2004 Nov 31; 28(11):1137-43. PubMed ID: 15380336
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tiazofurin: biological effects and clinical uses.
    Tricot G, Jayaram HN, Weber G, Hoffman R.
    Int J Cell Cloning; 1990 May 31; 8(3):161-70. PubMed ID: 2189014
    [Abstract] [Full Text] [Related]

  • 20. Modulation of nicotinamide adenine dinucleotide and poly(adenosine diphosphoribose) metabolism by the synthetic "C" nucleoside analogs, tiazofurin and selenazofurin. A new strategy for cancer chemotherapy.
    Berger NA, Berger SJ, Catino DM, Petzold SJ, Robins RK.
    J Clin Invest; 1985 Feb 31; 75(2):702-9. PubMed ID: 3919063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.